Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,791,900 | 3,375,900 | 3,093,300 | 3,268,400 | 3,369,000 |
| Marketable Securities | 121,600 | 170,100 | 127,400 | 154,800 | 149,400 |
| Receivables | 19,457,200 | 17,205,600 | 14,003,200 | 13,275,400 | 12,051,700 |
| Inventories | 12,180,400 | 11,013,800 | 9,311,000 | 7,589,200 | 7,459,800 |
| Other current assets | 271,500 | 68,800 | 72,400 | 111,400 | 134,600 |
| TOTAL | $62,071,300 | $49,854,000 | $41,261,200 | $32,739,700 | $31,415,100 |
| Non-Current Assets | |||||
| PPE Net | 22,316,000 | 20,529,700 | 18,474,100 | 17,102,400 | 16,171,800 |
| Investments And Advances | 2,808,300 | 3,207,400 | 3,222,700 | 3,215,900 | 3,200,200 |
| Intangibles | 6,446,700 | 5,908,300 | 6,012,200 | 6,166,300 | 6,537,300 |
| Other Non-Current Assets | 21,293,100 | 21,423,200 | 20,418,600 | 19,490,600 | 18,282,500 |
| TOTAL | $52,864,100 | $51,068,600 | $48,127,600 | $45,975,200 | $44,191,800 |
| Total Assets | $114,935,400 | $100,922,600 | $89,388,800 | $78,714,900 | $75,606,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 6,958,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,262,200 | 4,075,700 | 3,442,000 | 3,228,600 | 2,886,500 |
| Other current liabilities | 24,801,300 | 20,917,300 | 16,434,000 | 18,914,500 | 19,713,300 |
| TOTAL | $40,140,900 | $39,019,900 | $30,068,100 | $28,376,600 | $24,674,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,873,600 | 34,180,100 | 34,499,500 | 28,527,100 | 29,045,400 |
| Other Non-Current Liabilities | 10,070,100 | 9,373,500 | 8,974,400 | 7,539,600 | 7,566,700 |
| TOTAL | $50,943,700 | $43,553,600 | $43,473,900 | $36,066,700 | $36,612,100 |
| Total Liabilities | $91,084,600 | $82,573,500 | $73,542,000 | $64,443,300 | $61,286,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 945,384 | 946,457 | 947,736 | 948,170 | 949,316 |
| Common Shares | 591,400 | 592,000 | 592,600 | 592,400 | 593,900 |
| Retained earnings | 22,252,000 | 17,376,200 | 15,099,500 | 13,545,000 | 13,627,200 |
| Other shareholders' equity | -6,161,500 | -6,653,400 | -6,705,300 | -7,255,100 | -7,207,000 |
| TOTAL | $23,850,800 | $18,349,100 | $15,846,800 | $14,271,600 | $14,320,700 |
| Total Liabilities And Equity | $114,935,400 | $100,922,600 | $89,388,800 | $78,714,900 | $75,606,900 |